Health

Italy and France scientists in the new one “cell stem cells” magazine published report that they suffering from muscular dystrophy from the human body from the adult stem cells, genetically modified after implantation with the same muscle disease in mice has made significant therapeutic effect.

Reported that the results of this experimental therapy means that the medical profession in the use of autologous stem cell transplantation in the treatment of muscular dystrophy and the direction of a step forward. If in the future can be derived from stem cells genetically modified, to re-implant treatment in patients with the disease, which can effectively avoid the traditional myoblast transplantation treatment of the rejection.

Muscular dystrophy have different types, University of Milan, Italy, France, as well as a research scientist choice is the most common and most deadly “Duchenne muscular dystrophy” patients. According to statistics, the global average every 3,500 newborn baby out of a person suffering from the disease. Patients in preschool will continue to deteriorate due to a skeletal muscle weakness or atrophy, resulting in inconvenience to walk. Probably in the 7-year-old to 12 years old, will be completely lost his ability to walk, usually to be over 20 years of age because of cardiomyopathy, died of lung myasthenia gravis. At present against the disease, the medical profession there is no effective therapy.

Responsible for the study, of the University of Milan Yimotuolunte said in the application of this therapy to human clinical trials are necessary before a lot of research work, to improve their safety and effectiveness.